The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. - Test2 - elhamkhani - TriplyDB

The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy.

The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy.

http://www.wikidata.org/entity/Q35627680

about

Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction Dysfunction of Nrf-2 in CF epithelia leads to excess intracellular H2O2 and inflammatory cytokine production Montelukast prevents the decrease of interleukin-10 and inhibits NF-kappaB activation in inflammatory airway of asthmatic guinea pigs.The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs Epigenetics and chromatin remodeling play a role in lung disease Mechanism of telomerase activation by v-Rel and its contribution to transformation.Suppressing NF-κB and NKRF Pathways by Induced Pluripotent Stem Cell Therapy in Mice with Ventilator-Induced Lung Injury.Airway epithelial NF-κB activation promotes allergic sensitization to an innocuous inhaled antigen Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice.Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice.Role of type 2 deiodinase in response to acute lung injury (ALI) in mice.Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB.NFkappaB is persistently activated in continuously stimulated human neutrophils.Protective Effect of the Fruit Hull of Gleditsia sinensis on LPS-Induced Acute Lung Injury Is Associated with Nrf2 Activation.Apoptosis in lung injury and remodeling.Multiple anti-inflammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin B-induced lung injury.Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis Therapeutic effect of C-phycocyanin extracted from blue green algae in a rat model of acute lung injury induced by lipopolysaccharide.Increased expression of A Proliferation-inducing Ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: a possible link between COPD and lung cancer?Molecular mechanisms in chronic obstructive pulmonary disease: potential targets for therapy.Innate immune responses in house dust mite allergy.Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells.Changing the burden of COPD mortality Interactions of nanoparticles with pulmonary structures and cellular responses.Mechanisms of Disease: signal transduction in lung carcinogenesis -- a comparison of smokers and never-smokers.Analysis of the activation routes induced by different metal oxide nanoparticles on human lung epithelial cells.Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort Mitochondrial CaMKII inhibition in airway epithelium protects against allergic asthma.Immunomodulatory role of thymulin in lung diseases.Complex systems in pulmonary medicine: a systems biology approach to lung disease.A20 regulation of nuclear factor-κB: perspectives for inflammatory lung disease.Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells.Immune-related gene polymorphisms in pulmonary diseases.A disease-relevant high-content screening assay to identify anti-inflammatory compounds for use in cystic fibrosis.Protective effect of resveratrol on acute lung injury induced by lipopolysaccharide in mice.Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the toll-like receptor-MyD88 pathway.Inhibiting NF-κB in the developing lung disrupts angiogenesis and alveolarization.Anti-inflammatory effects of adrenomedullin on acute lung injury induced by Carrageenan in mice.Mifepristone-inducible recombinant adenovirus attenuates paraquat-induced lung injury in rats.

P2860

Q24647748-0E834489-A158-4FDD-B5C3-74766DCB844D Q28473822-B718A297-4D99-4D2E-96F1-DC16C788674D Q33253576-85F063CF-4BB9-4318-B8CE-AED601BA6701 Q33722537-3707343B-11BE-43C9-87BE-CD0C25A24AC2 Q34126445-00501708-3B8E-4540-98E5-BAD48BF201C3 Q34233162-225CFDFF-4562-43A1-AC7E-E755E13843ED Q34805925-1E880BC5-14CC-4BBF-B192-29170382FE0D Q34985619-E2F9BD27-7E26-4AE0-90F9-C87B14EF9247 Q35070866-FDEA8F12-62FB-4FFB-8AAF-148519077338 Q35087995-0C6FDE57-0551-4CBB-A016-01D8BD98341B Q35132254-17CF913F-E997-4A34-B1AB-666E8AF24523 Q35621354-835CB8C7-2CD5-474A-9496-4C7CBF6D175E Q35781348-E2433399-A1A1-4A8E-BCF0-D7CF8C0385CB Q35844096-8813BE6A-516A-4330-BD02-2404195EADF1 Q35852621-DC969ECE-4D0D-4EC8-926D-26AD9A360BB4 Q35883362-81273B35-A394-4912-9C3D-8F2745971870 Q36419299-AE3BF959-730F-4F10-9B61-4F542F2E92C4 Q36576621-26F49758-F23F-4C4D-A9C0-E833A06202F4 Q36737847-04946E16-E86B-4CA9-81FD-0CB8E48E6787 Q36760903-3E94EAB1-EB5B-4493-AC15-F0A5FA2043E6 Q36779299-7FF2A5DA-2884-4F0A-ADA6-0CDF3A1D4109 Q36857029-D9873FE2-D413-4763-9506-CDEBCCD7FB09 Q36984408-A12A0F55-8B49-4247-ACB3-2084468F55CC Q37018812-AD6BB970-9829-4DAC-83BD-A04F4770255C Q37080749-DB8963BA-D3D5-45DC-8AF7-265673C9373B Q37217229-76CBE8E4-7DF5-4DC7-AD9A-BD04184F0F25 Q37474438-AE6158F3-6160-48D1-800F-D6B25FB46426 Q37586590-FD437D0B-4DB1-48BC-AD39-593309CA07E8 Q37624358-966BEA91-61C0-4981-A10D-5EA29E167959 Q37670238-1A9958CD-B5AA-44D5-83BE-33A9A82A2130 Q37823792-B307254A-2E07-4D35-B1BE-F10B39A33C6A Q37829153-7F70FB42-F61E-48E3-915F-D03611F4FD49 Q38293726-A3FBA45F-07CF-4067-BA1A-715C20706F49 Q39214085-6C67CED4-0FDA-4190-82C2-3E1A2A6092C5 Q39644722-BE7B7A21-5A0D-4F5E-943B-C01FA384649A Q39787675-381B2094-19D4-44CD-85D5-280EFA5A4FF6 Q39950603-70A155EF-B4F3-43BC-B6C5-1A8A47D75119 Q41824496-F437908F-6345-4CD3-ABF6-3A38AAFD4D0B Q42181639-23980BCC-2260-4532-A616-B41A7CEC477C Q42219700-9CF39601-5F9E-4858-A8D2-2520AAB9B0F0

P2860

The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy.

http://www.wikidata.org/entity/Q35627680

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

The role of nuclear factor kap ...... ses: implications for therapy.

@ast

The role of nuclear factor kap ...... ses: implications for therapy.

@en

type

label

The role of nuclear factor kap ...... ses: implications for therapy.

@ast

The role of nuclear factor kap ...... ses: implications for therapy.

@en

prefLabel

The role of nuclear factor kap ...... ses: implications for therapy.

@ast

The role of nuclear factor kap ...... ses: implications for therapy.

@en

P1433

Q35627680-CD2DF55C-2CBE-4D8A-9586-1C50B206AC2C

P1476

Q35627680-13EABE15-A875-4948-8733-2E4E94C4BCDA

P2093

Q35627680-564BB490-A51A-40A9-9810-D9D9B243FF0A

Q35627680-D4D8C466-36B5-417B-A2C3-C6D792B2E796

P2860

Q35627680-05E1E377-7A1B-42CC-B2F8-E2386D0499EA

Q35627680-1692F991-1627-42EC-BD21-391DAE68B139

Q35627680-19857E28-6B56-4222-8FF9-60BDD6B67B98

Q35627680-19FAD8A3-1CD1-460C-ADA8-8F981993A8FE

Q35627680-1D68D27E-5A0D-44DC-80F1-20BE9605E013

Q35627680-1DD0A4B3-EFA2-44E9-B334-BA7F2EB2B2FA

Q35627680-250C91B6-DD65-42C3-97D9-61B372850020

Q35627680-260E19F7-8423-4C6C-9A49-5DD79E9D9D45

Q35627680-27B4DF37-BEB1-4D2B-B318-0598F1721DD7

Q35627680-35D94AAC-2DC4-422E-996B-DEFFD223FF0D

P2888

Q35627680-26F6D961-3E2B-4223-BA07-FBCFD1A07D18

P304

Q35627680-923A6084-5597-41BF-9B51-607DC0CBAFAE

P31

Q35627680-1E5A7739-3E56-4313-AFC3-E27FA37D87B6

Q35627680-710cbf44-7b6c-4119-a14e-a621e11472ef

P356

Q35627680-A29E7E06-0C87-4BA7-84A9-B0B7A70B757C

P433

Q35627680-5EFB802C-F7C0-4E9B-AC18-65BA8D1D356D

P478

Q35627680-B7E31F26-A06A-48D5-B3E8-0A946ED97371

P577

Q35627680-C9626246-C399-43B1-A5C1-47380179F540

P698

Q35627680-8FEDB799-FC81-4184-905F-FDDF901DAA7B

P356

P1433

Treatments in Respiratory Medicine

P1476

The role of nuclear factor kap ...... ses: implications for therapy.

@en

P2093

Jeffrey G Wright

http://www.w3.org/2001/XMLSchema#string

John W Christman

http://www.w3.org/2001/XMLSchema#string

P2860

Role of transcription factor NF-KB in asbestos-induced TNF-alpha response from macrophages

Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

The NF-kappa B and I kappa B proteins: new discoveries and insights

Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit

Bench-to-bedside review: Toll-like receptors and their role in septic shock.

Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants

Silica-induced pulmonary inflammation in rats: activation of NF Kappa B and its supression by dexamethasone

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

Duration of nuclear NF-kappaB action regulated by reversible acetylation

P2888

P304

211-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03256650

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14720003

http://www.w3.org/2001/XMLSchema#string